1660-2854
Bimonthly
No
NEURODEGENER DIS
2004
39
SWITZERLAND
http://www.karger.com/Journal/Home/229093
较慢,6-12周审稿时间
一般平均录用比例
2.6影响因子
临床神经病学小学科
137/285JIF RANK
1489总被引频次
月期刊平台服务过的文章录用时间为1-3个月,依据20年经验,经月期刊专家预审通过后的文章,投稿通过率100%以上!
《神经退行性疾病》是一本双月刊,多学科期刊,出版关于神经退行性疾病的研究进展,包括阿尔茨海默病、帕金森病、肌萎缩侧索硬化症、亨廷顿舞蹈症以及相关的神经和精神疾病。神经退行性疾病发布结果从基础和临床科学研究项目旨在更好地理解基因和蛋白质的正常功能参与神经退行性疾病,在疾病致病机制”来形容他们的作用,他们的功能模型动物和探索他们的角色在诊断、神经退行性疾病的治疗和预防。我们坚信,神经退行性疾病新疗法的成功策略将来自于基础神经生物学与临床科学的智能融合。因此,神经退行性疾病将接受来自分子和细胞生物学、神经科学、药理学、遗传学和临床科学等广泛科学研究领域的高质量论文。
http://oper1.karger.com/journals/default.asp?ProduktNr=229093
Neurodegenerative Diseases is a bimonthly, multidisciplinary journal for the publication of advances in the understanding of neurodegenerative diseases, including Alzheimer disease, Parkinson’s disease, amyotrophic lateral sclerosis, Huntington disease and related neurological and psychiatric disorders. Neurodegenerative Diseases publishes results from basic and clinical scientific research programs designed to better understand the normal functions of genes and proteins involved in neurodegenerative diseases, to characterize their role in pathogenic disease mechanisms, to model their functions in animals and to explore their roles in the diagnosis, treatment and prevention of neurodegenerative diseases. It is our firm belief that successful strategies for novel treatments of neurodegenerative diseases will emerge from the intelligent integration of basic neurobiology with clinical sciences. Therefore, Neurodegenerative Diseases will accept high-quality papers from a broad spectrum of scientific research areas ranging from molecular and cell biology to neuroscience, pharmacology, genetics and the clinical sciences.